ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment

Author(s): Rama Rao Malla*, Mohammad Amjad Kamal

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 28 , 2021

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


The breast tumor microenvironment (TME) promotes drug resistance through an elaborated interaction of TME components mediated by reactive oxygen species (ROS). Although there is massive accumulation of data concerning the targeting of the ROS, little is known about the ROS-responsive nanomedicine for targeting breast TME. This review submits the ROS landscape in breast TME, including ROS biology, ROS mediated carcinogenesis, and reprogramming of stromal and immune cells of TME. We also discussed ROS-based precision strategies for imaging TME, including molecular imaging techniques with advanced probes, multiplexed methods, and multi-omic profiling strategies. ROS-responsive nanomedicine also describes various therapies, such as chemo- dynamic, photodynamic, photothermal, sono-dynamic, immune, and gene therapy for BC. We expound ROS-responsive primary delivery systems for chemotherapeutics, phytochemicals, and immunotherapeutics. This review also presents recent updates on nanotheranostics for simultaneous diagnosis and treatment of BCs. We assume that a review on this advancing field will be beneficial to the development of ROS-based nano-theranostics for BC.

Keywords: Breast cancer, nanotechnology, precision medicine, ROS biology, tumor microenvironment, ROS mediated carcinogenesis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 08 December, 2020
Page: [5674 - 5698]
Pages: 25
DOI: 10.2174/0929867328666201209100659
Price: $65

Article Metrics

PDF: 299